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Young female mice on a C57Bl/6J (B6) background are
considered glomerulosclerosis (GS)-resistant but aging B6
mice develop mild GS. Estrogen deficiency accelerates while
estrogen replacement retards GS in young sclerosis-prone
oligosyndactyly mutant mice on an ROP background.
To explore the effects of sex hormones on glomerular
structure and function in the context of gender and genetic
background, we studied mice in which the estrogen-receptor
(ER) genes a- or -b were deleted (a- or bER knockout (KO)
and crossed into the B6 background. We also studied
ovariectomized (Ovx) B6 mice given testosterone. Male and
female bERKO and male aERKO mice had no glomerular
dysfunction at 9 months of age; however, aERKO female
mice displayed albuminuria and GS. Ovx prevented
glomerular dysfunction in aERKO female mice by eliminating
endogenous testosterone production while exogenous
testosterone induced GS in Ovx B6 mice. Androgen receptor
(AR) expression and function was found in microdissected
glomeruli and cultured mesangial cells. Testosterone
compared to placebo increased both AR expression and
TGF-b1 mRNA levels in glomeruli isolated from female B6
mice. Estrogen deficiency had no deleterious effects on the
glomeruli in B6 mice. Our study shows that genetic traits
strongly influence the GS-promoting effects of estrogen
deficiency while testosterone induces GS in a gender-specific
manner.
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Chronic kidney disease (CKD) affects about 20 million
adults and is a cause of morbidity and mortality in the
United States.1 However, the role sex hormones play in the
pathogenesis of CKD remains a matter of controversy. Some
clinical studies have reported a more rapid progression
of CKD in men than in women while others did not find
a gender difference.2–5 In contrast, the ‘ACE Inhibition in
Progressive Renal Disease Study Group’ recently suggested
that renal disease progression may be even faster in post-
menopausal women.3 Thus, the uncertainty concerning the
effects of sex hormones on the development and progression
of glomerulosclerosis (GS) in the context of gender, age, and
genetic traits (genetic background) persists.
Studies in experimental models of renal disease have
shown the detrimental effects of estrogen deficiency and
conversely the benefits of 17b-estradiol (E2) replacement.
6–9
We previously studied female ROP Os/þ mice which
spontaneously develop GS at a young age.8 The progression
of GS in female ROP Os/þ mice is accelerated and worsened
by experimental diabetes and unilateral nephrectomy. Most
importantly, the deterioration of glomerular function and
structure in female ROP Os/þ mice is dramatically hastened
by estrogen deficiency after ovariectomy (Ovx). E2 replace-
ment not only delays the onset but nearly eliminates
the progression of glomerular disease in ROP Os/þ mice.10
On the other hand, female C57/Bl6 (B6) mice do not develop
GS in response to noxious stimuli such as genetically induced
nephron reduction, unilateral nephrectomy, or experimen-
tally induced diabetes before menopause. Furthermore,
female B6 mice only develop mild glomerular lesions consis-
ting of glomerular hypertrophy, mesangial cell (MC) proli-
feration, and vascular pole sclerosis at 18–20 months of age
in the early phase of anestrous.11
In contrast to the reports on the glomerular effect of
estrogens, little data are available on androgen (testosterone)/
androgen receptor (AR) action in the glomerulus. Among
recently published studies, Ji et al.12 showed that dihydrotes-
tosterone administration contributed to renal disease induced
by renal wrap hypertension in rats. Another study in aging
spontaneously hypertensive rats reported that castration
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prevented glomerular injury and reduction in glomerular
filtration rate.13 Testosterone has also been shown to increase
apoptosis in human male proximal tubule kidney cells by
activating caspase, Fas upregulation, and FasL expression.14
While the above mentioned publications are not all inclusive,
gender-specific response(s) of the glomerulus to testosterone
have not been addressed in great detail. Interestingly,
testosterone production by the ovaries persists in woman after
menopause thereby changing the ratio of E2 to testosterone in
favor of the latter. This phenomenon may potentially contribute
to the faster progression of CKD in women after menopause.
To further explore the role of sex hormones in the
development and progression of GS in the context of gender
and genetics, we studied male and female mice in which the
respective genes of the estrogen receptor a (aERKO) or the
ERb (bERKO) were deleted by homologous recombination.
The aERKO and bERKO mice were previously backcrossed
for more than 10 generations onto a B6 genetic background.
Interestingly, female aERKO mice have higher E2 and
testosterone levels than female wild-type B6 mice because
of the activation of the hypothalamic–pituitary–ovarian axis
because of the lack of the wild-type ERa. Thus, aERKO and
bERKO mice are unique animal models to elucidate the role
E2, the respective ER subtypes, and testosterone play in the
glomerulus, specifically in mice, which are apparently
protected against GS by their genetic traits/background. We
also studied female B6 mice supplemented with testosterone
for comparison. Wild-type littermates and B6 mice served as
controls in our experiments.
RESULTS
Urinary albumin excretion
Intact female aERKO mice have higher urinary albumin
excretion (UAE) at 9 months of age compared to littermate
controls (0.03070.002 vs 0.1070.018, Po0.001, Figure 1a).
There was no increase in UAE in male aERKO, male and
female bERKO mice and their wild-type littermates (Figure
1b.) Interestingly, the increase in UAE did not follow a linear
time/UAE relationship but developed at around 7–8 months
of age (data not shown). UAE did not increase after unilateral
nephrectomy in aERKO mice (0.1370.03 vs 0.1070.018) or
wild-type littermate controls (0.01270.001 vs 0.0370.002).
Importantly, the increase in UAE was prevented in Ovx
aERKO mice to a level observed in intact wild-type mice
(0.1370.005 vs 0.0370.002, Po0.001, Figure 2). This could
have been due to decreased testosterone levels, since UAE was
increased by testosterone supplementation of Ovx B6 mice
compared to wild-type littermates (0.0170.007 vs 0.097
0.02, Po0.001, Figure 2).
Body, kidney, and heart weight
In intact mice, body weight was increased in female ERKO
mice vs female littermates (Table 1). Body weight was
increased in Ovx B6 mice, regardless of whether they were
supplemented with placebo or testosterone. Kidney weight
was only increased in testosterone-supplemented mice.
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Figure 1 | Urinary albumin excretion. (a) Intact female aERKO mice
and B6 mice substituted with testosterone (T) have albuminuria
which increases with age. Urine was collected once a month for the
duration of the study. Albumin/creatinine ratio (UAE) was determined
as described in Materials and Methods. There was a significant
increase in UAE in 9-month-old aERKO (.) compared to 3-month-old
aERKO mice and 9-month-old wild-type mice (m, **Po0.001). There
was no difference between 3-month-old aERKO and wild-type mice.
T (’) increased UAE of Ovx B6 mice (**Po0.001). Each point
represents an individual mouse. (b) UAE is increased only in Female
aERKO mice. Female aERKO (/) had a significantly higher UAE
compared to wild-type littermates (þ /þ ), male aERKO, and male
littermates (**Po0.001) compared to female and male bERKO and
bERKO littermates (*Po0.01). Each point on the graph represents
an individual mouse.
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Figure 2 | Removal of testosterone by Ovx decreases UAE in
9-month-old female aERKO mice. Urine was collected once a
month for the duration of the study. Albumin/creatinine ratio (UAE)
was determined as described in Materials and Methods. Ovx (Ovx)
reduced albumin/creatinine ratio in aERKO mice (., Intact vs Ovx,
*Po0.05). Conversely Testosterone (T) treatment increased albumin/
creatinine ratio compared to Ovx B6 (’, *Po0.05). Each point on
the graph represents an individual mouse.
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As described previously, aERKO serum testosterone levels
were approximately eight times higher than that of female
littermates.15 Testosterone supplementation of Ovx B6 mice
increased testosterone to levels approximately threefold
higher than those of Sham B6 mice.
Testosterone and E2 levels were significantly decreased in
Ovx aERKO mice. As expected, E2 supplementation resulted
in increased uterine weight in wild-type littermate mice but
not in aERKO mice.
Histology
There was an increase in glomerular size in 9-month-old
female aERKO mice compared to wild-type B6 mice and other
ERKO groups (Figure 3a and b). In addition, diffuse mesangial
matrix expansion was noted. Glomerular cell number was not
increased and no arteriolar lesions were identified. Tubular or
interstitial lesions were not present in any of the animals.
Glomerular area and volume
There was a conspicuous increase in glomerular size in
aERKO mice (Figure 4). However, glomerular size was
less prominent in Ovx aERKO mice (16191eþ 0067
1.8548eþ 006 vs 898831171223eþ 006, Po0.001). The
glomerular volume of Ovx aERKO mice was similar to that
of intact or Ovx wild-type or Ovx B6 mice. In contrast,
testosterone supplementation increased glomerular volume
in Ovx B6 mice (Figure 3, 1.0040eþ 00671.1664eþ 006 vs
1.3735eþ 00671.7987eþ 006, Po0.005). As expected, Ovx
aERKO mice replaced with E2 were not different than Ovx
aERKO mice that received placebo (data not shown).
Extracellular matrix accumulation
There was an increase in laminin and collagen deposition in
female aERKO mice (Figure 5b). This was less marked in Ovx
aERKO mice (Figure 5d). Increased matrix deposition was also
evident in B6 mice supplemented with testosterone (Figure 5f).
AR expression
Glomerular AR mRNA expression was twofold higher in
female aERKO mice than intact female wild-type littermates
Table 1 | Group I (female mice without nephrectomy)
Intact wild-type
(9 months)
Intact aERKO
(9 months)
Sham B6
(9 months)
B6 Ovx P
(9 months)
B6 Ovx+T
(9 months)
n 7 7 5 5 6
Body weight (g) 26.3472.84 33.7173.34***a 25.4471.78 32.573.56**b 31.173.28**b
Kidney weight (g) 0.2270.033 0.2470.087 0.2470.04 0.270.02 0.3270.06**c
Kidney weight/ Body weight ratio (g) 0.00870.0008 0.00770.002 0.0070.001 0.00670.0002 0.017 0.001
Uterus weight (g) 0.10770.027 0.06370.017***d 0.1470.078 0.02570.03*e 0.02870.008*e
Serum E2 concentrations pg/ml (7s.e.m.) 18.2077.02 61.9974.03 1572.9 10.4771.6 10.671.2
Serum T concentrations ng/ml (7s.e.m.) 0.1870.03 1.5670.17**a 0.1670.03 0.0870.02 0.3470.09
E2, 17b-estradiol; ERKO, estrogen receptor knockout; Ovx, ovariectomy, P, placebo; T, testosterone.
*Po0.05, ** Po0.005, *** Po0.0005.
aVs wild-type.
bVs intact B6.
cVs intact b6.
dVs intact wild-type.
eVs intact B6.
a b
dc
Figure 3 | Light microscopy. Methacrylate-embedded sections were
stained with periodic acid-Schiff silver methanamine. (c) Sections
from (a) a wild-type littermate mouse and (b) an intact female aERKO
mouse. (c) Sections from an Ovx B6 mouse and a (d) testosterone
(T)-supplemented Ovx B6 mouse. Original magnification  400.
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Figure 4 | Ovx reduces the expanded glomerular volume in
aERKO mice. Glomerular volume was measured as described in
Materials and Methods. The glomerular volume of Ovx aERKO (.)
mice is similar to that of intact or Ovx wild-type (m) or Ovx B6 (’)
mice. Testosterone (T) supplementation increases glomerular volume
in Ovx B6 mice (’, *Po0.05, ***Po0.005). Each point on the graph
represents individual mice.
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and B6 mice (Po0.05, Figure 6). Testosterone treatment
increased glomerular AR mRNA expression in Ovx B6 mice
(Figure 6). There was no difference between female and male
aERKO mice with respect to glomerular AR expression. The
levels of AR mRNA were about twofold higher in the
glomeruli of male aERKO mice compared to those of wild-
type males (Figure 7a). The levels of AR protein expression
were similar in the MCs of aERKO males and their male wild-
type littermates as shown by Western analysis (Figure 7b).
Androgen responsiveness of MCs
MCs isolated from female aERKO mice and wild-type
littermates were transfected with a reporter gene under the
transcriptional regulation of androgen response elements
(pARE2-tk-LUC). Testosterone increased reporter gene acti-
vity in MCs isolated from female aERKO mice (Figure 8b),
but not in those from wild-type littermates (Figure 8a). The
increased androgen responsiveness in female aERKO MC is,
in part, mirrored by the higher glomerular AR expression
(Figure 6).
Expression of glomerular ERa variants
Alternatively spliced ERa mRNA variants have been reported
previously in the uterine tissue of female aERKO mice
and have been termed E1 and E2.16 We only detected the
a b
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e f
Figure 5 | Testosterone increases glomerular laminin
accumulation. Immunofluorescence staining of laminin. (a) Wild-type
littermate control, (b) 9-month-old aERKO female,
(c) intact aERKO, (d) Ovx aERKO, (e) Ovx B6 mouse, and
(f) testosterone-supplemented Ovx B6 mouse. Original
magnification  400.
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Figure 6 | Glomerular androgen (AR) mRNA expression is
higher in intact aERKO than in intact B6 mice. Testosterone (T)
supplementation increases AR mRNA levels in Ovx B6 mice.
Real-time polymerase chain reaction was performed to assess
mRNA expression of AR. Data are expressed as a ratio of AR/18s
(*Po 0.05), n¼ 5.
*
*
*
AR
/1
8s
AR
 p
ro
te
in
 (d
en
sti
om
etr
y 
un
its
)
Wild-type Wild-type
Male MaleFemale Female
ERKO ERKO
Wild-type Wild-type
Male MaleFemale Female
ERKO ERKO
2000a
b
Glomeruli
Mesangial cells
1500
1000
500
0
1 2 3 4
20 000
15 000
10 000
5000
0
Figure 7 | Expression of glomerular AR mRNA and MC AR protein
are higher in intact aERKO than in intact B6 mice. (a) AR mRNA
expression was assessed in glomeruli by real-time reverse
transcriptase-polymerase chain reaction. (b) AR protein was analysed
in protein extracts isolated from MCs of wild-type littermates and
aERKO male and female mice. (a) Data are expressed as the ratio
of AR/18s, n¼ 4/group. *Po0.05 wild-type male vs aERKO male,
wild-type female vs aERKO female. (b). Inset depicts representative
Western blot of MC AR. Protein extraction from MCs and Western blot
analysis were performed as described in Materials and Methods. Lane
1: aERKO male, lane 2: wild-type female, lane 3: aERKO female, lane 4:
wild-type male. Densitometry data from three experiments were
graphed7s.e.m, *Po0.05 aERKO female compared to wild-type
littemate female.
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E2 variant in glomerular mRNA of aERKO mice, which does
not translate into a mutant ER (data not shown). This
is consistent with the earlier report by Couse et al.17 who also
did not detect the E1 variant in the brain, kidney and liver
of aERKO mice.
Glomerular TGF-b1 expression
Transforming growth factor (TGF)-b signaling is widely
viewed as an intracellular signaling pathway that promotes
GS, especially in diabetes.6,18–21 We and others have found
that estrogen treatment decreases TGF-b1 expression in MCs
and glomeruli.9,10,22,23 Intact female aERKO have higher
glomerular mRNA levels of TGF-b1 than wild-type litter-
mates and B6 mice (Po0.05, Figure 9). Treatment of Ovx B6
mice with testosterone increased glomerular TGF-b1 expres-
sion to a level that was similar to that found in intact female
aERKO mice (Figure 9). Ovx did not change glomerular
TGF-b1 expression in B6 mice.
TGF-b1 signaling pathway
To test whether the intracellular TGF-b1 receptor/Smad
signaling system was intact in MCs isolated from female
aERKO and their littermate controls, we transfected cells with
a TGF-b1 responsive luciferase reporter construct (p3TP-
Lux). TGF-b1 increased transcription in MC isolated from
both aERKO (Figure 10a) and intact wild-type mice (Figure
10b). There was no difference in the response to TGF-b1.
DISCUSSION
The paucity of controlled clinical studies in humans
examining the role of E2 and testosterone in the pathogenesis
of GS, especially in the context of gender, age and genetic
traits, is largely responsible for the controversy that still
exists concerning the beneficial or unfavorable effects of sex
hormones on the glomerulus. We previously showed that the
glomerulus is an estrogen-target tissue and that estrogens
via the ERa regulate genes, especially those involved in
extra cellular matrix turnover, in a manner that is protective
against GS.24,25 We subsequently reported that estrogen
deficiency accelerated the progression8 and E2-replacement
retarded the development of GS in Ovx sclerosis-prone
female ROP Os/þ mice.10 In contrast, female B6 mice are
sclerosis-resistant at a young age and only develop a mild
form of GS at 15–20 months of age in early anestrus, that is
rodent menopause.11 These findings raised the questions
whether estrogen deficiency has a detrimental effect on the
glomerulus and whether testosterone promotes GS.
Thus, to examine the effects of estrogens and the distinct
role of ERa and ERb in the protection against GS in sclerosis-
resistant mice, we first studied intact and Ovx female B6 mice
as well as aERKO and bERKO, all on a B6 background, and
their wild-type littermate controls. We also examined male
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Figure 8 | MCs isolated from female aERKO mice exhibit increased
androgen responsiveness. MCs isolated from (a) female wild-type
littermates and (b) aERKO mice were transfected with a reporter gene
under the transcriptional regulation of androgen response elements
(pARE2-tk-LUC). There was an increase in reporter gene activity in
response to testosterone only in cells from aERKO mice (*Po0.05).
Data are expressed as % of vehicle control. Mean7s.e.m. of cell
lysates collected from two individual cell lines obtained from each
treatment group are shown. Triplicate wells were collected for
each concentration of testosterone (*Po0.05 compared to control,
n¼ 3 individual collections).
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Figure 9 | The mRNA expression of TGF-b1 is higher in glomeruli
isolated from intact female aERKO than in those from intact
female or Ovx B6 mice (Ovx/P). Treatment with testosterone
(Ovx/T) increases TGF-b1 mRNA expression in the glomeruli of Ovx B6
mice. Data are expressed as a ratio of TGF-b/18s (*Po0.05), n¼ 5.
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Figure 10 | TGF-b1 increased transcription in MC isolated from
(a) aERKO and (b) intact wild-type mice. MC were transfected
with a construct containing three smad-binding elements (p3TP-Lux,
0.3mg/well) and cotransfected with the b-galactosidase gene
(0.5mg/well). MC were exposed to increasing concentrations of
TGF-b1 (0–500 pg/ml) and collected as described in Materials and
Methods. There was no difference in the response to TGF-b1. Data
are expressed as % of vehicle control. Mean7s.e.m. of cell
lysates collected from two individual cell lines for each mouse
treatment group are shown. Triplicate wells were collected for each
concentration of TGF-b1 (*Po0.05, n¼ 2 individual collections).
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aERKO and bERKO mice to address potential gender-related
differences in GS in response to ER deletions.
Intact female and Ovx B6 mice did not develop
microalbuminuria, an early and sensitive marker of glome-
rular damage, over the 6-month study period. Similarly, UAE
was normal in male aERKO and female and male bERKO
mice at 9 months of age. This suggested that neither systemic
estrogen deficiency over a 6-month period in young
9-month-old B6 mice nor the absence of functional ERa in
male B6 (aERKO) nor the lack of ERb in female and male
B6 (bERKO) mice affected UAE.
On the contrary, intact female aERKO mice displayed
increased UAE, increased glomerular size, and mesangial
laminin accumulation at 9 months of age. The morphological
changes, consistent with GS, correlated well with the
albuminuria observed in intact female aERKO mice. How-
ever, these contrasting observations, such as the absence of
UAE or glomerular pathology in estrogen-deficient B6 mice
vs the pronounced glomerular dysfunction and histological
changes in intact female aERKO mice, suggested an
indirect rather than a direct effect of the lack of ERa on
the glomerulus. In fact, disruption of the estrogen/ERa-
mediated negative feed-back on the hypothalamic–pituitary–
ovarian axis results in luteinizing hormone-driven
ovarian hyperstimulation ultimately leading to increased
gonadal synthesis of E2 and testosterone in intact female
aERKO mice.15 Ectopic expression of the Hsd17b3 gene,
which encodes the enzyme 17b-HSD III, is caused by chronic
luteinizing hormone elevation and is responsible for the
extraordinarily increased capacity of the aERKO ovaries to
synthesize testosterone via conversion of androstendione.17
Accordingly, the ovaries of intact female aERKO mice show
large, hemorrhagic, and cystic follicles. As a result, serum
testosterone concentrations rise in female aERKO mice to
levels that are about eight times higher than those in female
littermates. By comparison, female aERKO testosterone levels
are only 1/3 of those in male wild-type littermates and about
1/5 of those of male aERKO mice, respectively.15 Although
endogenous E2 levels are also elevated in intact female
aERKO, glomerular estrogen action is impaired because of
the absence of a functional wild-type ERa. Furthermore, male
aERKO did not develop GS despite their higher testosterone
levels compared to female aERKO mice and male wild-type
littermates. These phenomena were observed despite similar
levels of glomerular AR mRNA and mesangial AR protein
expression in male and female aERKO mice. Absence of
glomerular scarring in aERKO males was also observed
despite the presence of about twofold higher glomerular AR
mRNA concentrations and similar mesangial AR protein
levels in aERKO males compared to wild-type males. These
findings underscore the gender-specific effects of sex
hormones on the glomerulus.
Taken together, these data suggested that endogenous
testosterone, via direct glomerular androgen action, induced
GS in female B6 mice which are resistant to the development
of GS before anestrous (rodent menopause) in response to
genetically induced nephron reduction, unilateral nephrec-
tomy, or experimentally induced diabetes. To test the
hypothesis that androgens induce GS in female B6 mice, we
treated Ovx B6 mice with testosterone using subcutaneously
implanted pellets. As predicted, Ovx B6 mice developed
microalbuminuria and GS similar to what was observed in
intact female aERKO mice. Reciprocally, Ovx of aERKO
mice, which were simultaneously and unilaterally nephrecto-
mized (Nx) as an additional renal injury, did not develop
increased UAE or GS.
Expression of AR mRNA and protein was assessed in
glomeruli and MCs by real-time reverse transcriptase-
polymerase chain reaction and Western analysis. The func-
tional activity of the AR in MCs was shown by T-testosterone
mediated stimulation of a transfected androgen responsive
luciferase-based reporter gene. These studies confirmed
that the glomerulus is a direct target tissue for testosterone
by demonstrating, for the first time to our knowledge, the
expression of functional AR in glomerular cells. In female
mice, AR expression in glomeruli and MCs was highest in
intact aERKO compared to their wild-type littermates.
Testosterone replacement of Ovx B6 mice increased glome-
rular AR expression. This suggests that glomerular AR
expression in female mice is positively regulated by andro-
gens, similar to ER expression in glomeruli.24
Interestingly, sex steroids have been previously shown to
positively regulate AR in reproductive as well as in non-
reproductive tissues other than the glomerulus. For instance,
testosterone upregulates AR gene expression in primate
ovaries, where AR are most abundant in the granulosa cells of
healthy, growing follicles.26 Bilateral orchiectomy caused a
severe loss of both AR and ER staining in male excurrent
ducts of goats.27 On the contrary, testosterone increased AR
expression in the Harderian glands of male hamsters28 and
Pelletier et al.29 reported that estrogens exert positive
regulation of AR mRNA expression in the uterus and vagina
of adult mice.
Estrogen replacement of Ovx/Nx aERKO mice had no
impact on UAE and was similar to that observed in placebo-
treated Ovx/Nx aERKO mice. Thus, ERb activation in female
aERKO mice via elevated endogenous E2 levels had no
adverse effects or beneficial effects on glomerular function.
Involvement of the TGF-b1 system was also demonstrated.
TGF-b1, a pleiotropic cytokine, is generally considered a
progression factor for GS because of increased expression or
activation of the TGF-b1 system in virtually every type of
CKD in humans as well as in experimental kidney injury
models.8,10,30,31 Activation of the TGF-b1/Smad signaling
pathway regulates glomerular gene expression in a manner
that results in extra cellular matrix accumulation especially in
the mesangium.6,8,10,31–39 TGF-b1 expression was higher in
the glomeruli of female aERKO mice than in those of wild-
type littermates. The Ovx-induced fall in the elevated serum
testosterone levels in female aERKO mice was associated with
lower glomerular TGF-b1 mRNA levels. Conversely, testo-
sterone supplementation increased glomerular TGF-b1
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mRNA expression in female B6 mice. This appears to be
in direct contrast to other androgen-sensitive organs. For
example, in the prostate androgens suppress TGF-b1, most
probably through direct binding of AR to Smad3. These data,
in the context of previous studies, provide important
evidence for the complex regulation of glomerular TGF-b1
expression by sex hormones. On the one hand, estrogen
deficiency increased glomerular TGF-b1 mRNA expression in
Ovx sclerosis-prone ROP Os/þ mice, a phenomenon that is
reversed by E2 supplementation.
8,10 In contrast, testosterone
increases TGF-b1 mRNA levels in the glomeruli of female B6
mice. As the TGF-b1/Smad signaling pathway is functional
and remains intact in the absence or presence of sex steroids
in MCs, sex hormone regulation of TGF-b1 expression
appears to be a crucial step in regulating the activation of the
prosclerotic TGF-b1/Smad signaling pathway.
In summary, these data demonstrate a unique and gender-
specific susceptibility to testosterone that is responsible for
inducing GS in young female B6 mice which are resistant to
GS in response to other pathological stimuli. The sclerosis-
inducing effects of testosterone may be self-perpetuating via
upregulation of AR in glomeruli and MCs and are potentially
mediated via activation of the prosclerotic TGF-b1 signaling
cascade. If such data are confirmed in humans, it may inject
a note of caution against testosterone replacement in
postmenopausal woman especially those with existing CKD.
Furthermore, this study in conjunction with previous reports
from our laboratory demonstrates the different, even contrast-
ing, effects of sex hormones on the glomerulus.8,10,24,40 These
data expose the difficulties to draw conclusions on the effect of
sex hormones on the glomerulus without knowledge of the
specific genetic background of the individuals studied.
MATERIALS AND METHODS
ERKO mice: a murine model to study effects of sex hormones
on the development and progression of GS
ERKO mice are transgenic mice engineered by homologous
recombination of a neomycin-cassette leading to disruption of the
ERa or ERb gene, respectively.17 Female aERKO have higher
circulating E2 and testosterone and male aERKO mice display
elevated testosterone levels compared to wild-type littermates,
respectively. Their progesterone and follicle-stimulating hormone
levels remain in the normal range. In contrast, male and female
bERKO mice have luteinizing hormone, E2, and testosterone levels
similar to those of wild-type mice.
Animals
Male and female ERKO mice and their wild-type littermates were
obtained from Taconic farms (Germantown, NY). B6 mice were
obtained from Jackson Laboratories (Bar Harbor, ME). Group 1:
sham male and female ERKO mice which were aged and female
sham B6 mice. B6 mice were Ovx at 3 months of age using
the previously described procedure approved by the Committee
For Animal Safety at the University of Miami School of Medicine8
and replaced with 90-day time-release pellets either with placebo
or testosterone pellets (12.5 mg/pellet) (Table 1). Group 2: female
aERKO mice were either Nx or Nx and Ovx (Nx/Ovx) at 3–4
months of age. E2 or placebo was administered to the mice via
90-day time-release pellets (Innovative Research of America,
Sarasota, FL, USA) (Table 2). The E2 pellets contained 0.05 mg/
pellet, which maintained E2 blood levels at 50–75 pg/ml. The 3 mm
pellets were implanted subcutaneously into the back of the animals
using a sterile trochar and forceps. These pellets were replaced every
90 days during the course of the experiment.
Animal killing
Mice were allowed free food and water and were killed at either 3 or
9 months of age. As described previously, the left kidney was
perfused with a buffer solution containing collagenase and RNAse
inhibitors for microdissection of glomeruli. The right kidney was
perfused in situ with 6 ml of phosphate-buffered saline and 3 ml of
4% paraformaldehyde, post-fixed in 4% paraformaldehyde solution
for at least 12 h and embedded in methacrylate. Sections, which were
4 mm thick, were stained with periodic acid–Schiff stain. Other
kidney fragments were immediately frozen in OCT.
Measurements of urinary albumin and creatinine
Urine samples were collected once a month and at the time of
killing. Albumin excretion was measured by enzyme-linked
immunosorbent assay (Bethyl, Houston, TX, USA), corrected for
creatinine concentration in the urine (kit using the Jaffe method,
Stanbio, San Antonio, TX) and expressed as the urinary albumin/
creatinine excretion ratio (UAE).
Measurements of E2 and T
Serum E2 and testosterone concentrations were measured in each
group by a competitive enzyme immunoassay kit (Active Estradiol
EIA kit DSL-10-4300 or Testosterone EIA kit DSL-10-4000;
Diagnostic Systems Laboratories Inc,. Webster, TX).
Morphometry
A morphometric approach was employed to quantify the degree of
GS.41 Fifty cortical glomeruli, randomly selected from each mouse,
Table 2 | Group 2 (female mice with nephrectomy)
Wild-type aERKO Wild-type Ovx/P
Wild-type Ovx/
17b-estradiol (E2) aERKO Ovx/P aERKO Ovx/E2
n 5 4 12 5 10 10
Body weight (g) 26.4473.43 37.8372.98**a 27.0273.91 26.7672.62 28.5874.4 25.3171.40
Uterus weight (g) 0.1570.002 0.0670.015 0.0270.003 0.0870.09*c 0.0270.01 0.0270.005
Serum E2 concentrations (pg/ml7s.e.m.) 2070.89**
b 6374.0 12.97 0.57 15.8872.9 10.5971.4**b 27.0479.5**b
Serum T concentrations (ng/ml7s.e.m.) 0.0870.03**b 3.571.1 0.1670.03 0.2270.07 0.1470.02**b 0.1970.02**b
E2, 17b-estradiol; ERKO, estrogen receptor knockout; Ovx, ovariectomy, P, placebo; T, testosterone.
a**Po0.001 a compared to all groups.
b**Po0.001 compared to ERKO intact.
c*Po0.01 compared to wild-type Ovx/P.
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were recorded with an Olympus BH-2 microscope and Micro Image
A209RGB color video camera. Glomerular volume (mm3) and
mesangial area (mm2) were measured using MetaMorph 4.5.4
Imaging System computer program (Universal Imaging Corpora-
tion, West Chester, PA).
Immunofluorescence staining
Cryostat sections of 4-mm thickness were exposed to either rabbit
anti-mouse collagen type IV (Biodesign, Saco, ME), rabbit anti-
mouse laminin (Research Diagnostics, Flanders, NJ, USA), IgG, and
IgM followed by goat anti-rabbit-conjugated fluorescein–isothiocya-
nate. The sections were examined and graded on a scale of 0–4 by a
renal pathologist blinded to the origin of the kidney slides.
Isolation of RNA and quantitative analysis of RNA expression
by real-time reverse transcriptase-polymerase chain reaction
Total RNA was extracted from 100 glomeruli, microdissected from
each animal, using the guanidinium thiocyanate–phenol–chloroform
method as described.24 Amplification and quantification of target
RNAs were performed on an ABI PRISM 7700 sequence detection
system (Applied Biosystems, Foster City, CA, USA).25 TaqMan
probes and primers for amplification of the specific transcripts were
designed using the Primer Express 1.5 from Applied Biosystems.
Primer sequences were identified with Tm values 101C less than the
probe. The TaqMan probes were labeled with the reporter dyes FAM,
VIC, or TET at the 50 end and with the quencher dye TAMRA at the
30 end. The primers and probes for TGF-b1, AR, and 18s
(endogenous controls) were synthesized commercially (Applied
Biosystems, ABI Primer & Probes, Foster City, CA, USA) TaqMan.
Cell culture
Glomeruli were microdissected and outgrowing MCs were isolated
propagated and identified as described previously.24 Cell culture
experiments were performed on cells between passages 3 and 10. All
experiments were performed on two independent cell lines/group.
Cells were maintained for experiments in phenol red-free Dulbecco’s
modified Eagle’s medium F12 containing 20% charcoal-stripped
serum as described previously.24
Western analysis
Protein (150 mg) was incubated overnight with AR antiserum and
protein A-agarose. The immunoprecipitates were washed four times
in phosphate-buffered saline and resuspended in 40ml of phosphate-
buffered saline. Western analysis was performed as described
previously to determine the presence of AR protein.24
Determination of glomerular ERa variants in aERKO mice
The expression of potential ERa variants in the glomerulus of
aERKO mice was determined by a polymerase chain reaction-based
method as described previously.17
Transfection studies
MC were transfected with either a construct containing three Smad-
binding elements (p3TP-Lux (0.3 mg/well), a gift from J Massague,
Sloan Kettering, NY) or an androgen response element (pARE2-
tk-LUC (0.5 mg/well), a kind gift from Professor Janne, University
of Helsinki, Finland) as described previously.10,22
Statistical analysis
All values were expressed as mean7s.e.m. Significance of differences
between experimental groups was determined by analysis of
variance. The two-tailed unpaired Student’s t-test was used to
evaluate differences between means of corresponding sets of data
obtained from 3- and 9-month-old mice.
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